Big Data innovations offer exciting opportunities for bone marrow transplant professionals and hematologists to rapidly select the most promising treatment for their patients. HARMONY invites bone marrow transplant professionals to become involved.
Experts of the HARMONY Alliance will be presenting at EBMT2023. We are also honored to organize a joint session with EBMT, find below more information.
Would you like to meet us at EBMT2023? Please send an email to communications@harmony-alliance.eu to set up an appointment.
Big Data innovations for bone marrow transplant professionals: Learn about the new ‘tools’ to rapidly select the most promising treatment for blood cancer patients and become involved in EBMT-HARMONY novel transplant studies using big data analytics.
HARMONY-EBMT Joint session
Day/time: Monday, 24 April 2023 | from 09:00 - 10:15 | Session number: JS01 room 143
Speakers:
HARMONY-EBMT Joint Session Program
EBMT is a valued HARMONY and HARMONY PLUS Partner. More information about EBMT2023, click here >
View here details about the HARMONY Alliance participation in EBMT 2022 >
#bigdataforbloodcancer: Accelerating Better and Faster Treatment for Patients with Hematologic Malignancies.
#bigdataforbloodcancer: Accelerating Better and Faster Treatment for Patients with Hematologic Malignancies.
The HARMONY Alliance (HARMONY and HARMONY PLUS) is a public-private European Network of Excellence for Big Data in Hematology. Our mission is to unlock and spread valuable knowledge on hematologic malignancies (blood cancers) among a large number of stakeholders, with the goal to harness and mine Big Data to speed up the development of improved treatments for patients and more effective treatment strategies. HARMONY is a partnership with more than 140 organizations such as hospitals, research institutes, patient organizations, pharmaceutical companies, regulatory agencies, IT companies, and medical network and associations such as EBMT. Together, they have developed the HARMONY Big Data Platform and the HARMONY Datalake, which contains anonymized data records from tens of thousands of blood cancer patients. This unique research infrastructure, with advanced big data analytic and AI tools, is being used to accelerate the development of more effective treatments for patients with hematologic malignancies (blood cancers).
HARMONY has identified more than 156,000 patient datasets and has transferred more than 73,000 datasets into the HARMONY Big Data Platform. Careful procedures have been installed to ensure the anonymization and quality of the data. In addition, HARMONY data scientists have developed sophisticated methods for data harmonization and analysis. Dedicated Research Project teams are currently using the Big Data Platform to answer critical research questions that cannot be addressed with other methods.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
